Nascent Biotech Inc (NBIO)
0.0870
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Nascent Biotech 1 Year Total Returns (Daily): 42.61% for June 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 14, 2024 | 42.61% |
| June 13, 2024 | 46.48% |
| June 12, 2024 | 87.36% |
| June 11, 2024 | 116.5% |
| June 10, 2024 | 144.7% |
| June 07, 2024 | 65.08% |
| June 06, 2024 | 115.3% |
| June 05, 2024 | 76.13% |
| June 04, 2024 | 93.55% |
| June 03, 2024 | 112.9% |
| May 31, 2024 | 121.0% |
| May 30, 2024 | 77.19% |
| May 29, 2024 | 69.10% |
| May 28, 2024 | 68.08% |
| May 24, 2024 | 78.03% |
| May 23, 2024 | 102.0% |
| May 22, 2024 | 99.20% |
| May 21, 2024 | 54.84% |
| May 20, 2024 | 54.69% |
| May 17, 2024 | 38.19% |
| May 16, 2024 | 38.67% |
| May 15, 2024 | 41.42% |
| May 14, 2024 | 79.12% |
| May 13, 2024 | 79.12% |
| May 10, 2024 | 96.46% |
| Date | Value |
|---|---|
| May 09, 2024 | 88.66% |
| May 08, 2024 | 98.00% |
| May 07, 2024 | 92.80% |
| May 06, 2024 | 95.69% |
| May 03, 2024 | 91.92% |
| May 02, 2024 | 67.73% |
| May 01, 2024 | 63.03% |
| April 30, 2024 | 65.67% |
| April 29, 2024 | 65.67% |
| April 26, 2024 | 67.34% |
| April 25, 2024 | 66.50% |
| April 24, 2024 | 50.77% |
| April 23, 2024 | 23.58% |
| April 22, 2024 | 30.22% |
| April 19, 2024 | 87.22% |
| April 18, 2024 | 67.91% |
| April 17, 2024 | 65.80% |
| April 16, 2024 | 61.86% |
| April 15, 2024 | 102.9% |
| April 12, 2024 | 59.20% |
| April 11, 2024 | 30.88% |
| April 10, 2024 | 20.00% |
| April 09, 2024 | 75.32% |
| April 08, 2024 | 67.32% |
| April 05, 2024 | 128.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-86.25%
Minimum
Aug 11 2023
456.0%
Maximum
Sep 23 2022
18.53%
Average
-18.18%
Median
Apr 27 2020
1 Year Total Returns (Daily) Benchmarks
| NovaBay Pharmaceuticals Inc | -89.69% |
| Palatin Technologies Inc | -15.26% |
| iBio Inc | -81.45% |
| Theriva Biologics Inc | -63.57% |
| Oragenics Inc | -44.22% |